Akari Therapeutics, Plc Announces $6.0 Million Registered Direct Offering
NEW YORK and LONDON, Dec. 30, 2021 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX) (“Akari” or the “Company”), a...
NEW YORK and LONDON, Dec. 30, 2021 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX) (“Akari” or the “Company”), a...
Company announcement – No. 78 / 2021 Total number of shares and voting rights in Zealand Pharma at December 30,...
IRVING, TX, Dec. 30, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Gibson Diagnostic Labs, a leading clinical diagnostic laboratory, hosted its inaugural...
Minneapolis, MN, Dec. 30, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- The Good Clinic, a leading operator of primary care clinics that...
COVAXIN™ whole virus inactivated vaccine generated broad antibody response comparable to those seen in a large phase 3 trial in adults...
Vancouver, British Columbia--(Newsfile Corp. - December 31, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has announced...
The Clinic is Accepting New Patients as of Today and Doors Will Be Open January 4th, 2022VANCOUVER, BC / ACCESSWIRE...
GOTHENBURG, SE / ACCESSWIRE / December 31, 2021 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)IRLAB (Nasdaq Stockholm: IRLAB A). Martin Nicklasson has...
TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on the development and commercialization of an...
VANCOUVER, BC / ACCESSWIRE / December 30, 2021 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused...
VANCOUVER, BC, Dec. 30, 2021 /PRNewswire/ -- Trait Biosciences Inc., a leading cannabinoid biotechnology research organization, announced that it has...
SAN DIEGO, Dec. 30, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer,...
WOBURN, Mass., Dec. 30, 2021 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...
Company now expects to release topline 52-week results from MAESTRO-NAFLD-1 in January 2022CONSHOHOCKEN, Pa., Dec. 30, 2021 (GLOBE NEWSWIRE) --...
NEW YORK, Dec. 30, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (the “Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today...
- Positive Phase 3 data in 2nd/3rd line NSCLC (Dublin-3): Superior efficacy benefit in plinabulin and docetaxel combination in overall...
VANCOUVER, British Columbia, Dec. 30, 2021 (GLOBE NEWSWIRE) -- Lotus Ventures Inc. (CSE: J) (OTC: LTTSF) (“Lotus” or the “Company”),...
CEO Schreiber to discuss changes made possible via proprietary virtual care platformsNEW YORK, Dec. 30, 2021 (GLOBE NEWSWIRE) -- LifeMD,...
WALTHAM, Mass., Dec. 30, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership,...
Meet with InMed’s CEO Eric A. Adams, Shane Johnson, SVP and General Manager of BayMedica and Chris Meiering, VP of...